Poly[6,6′-bis(ethylene-3,4-dioxythien-2-yl)]-N,N′-dialkylisoindigo (PBEDOT-iI)
was synthesized
and incorporated as an electroactive material into electrochemical
supercapacitors (ESCs) in type I and type III configurations. In type
I ESCs, PBEDOT-iI provides a specific power of ∼360 W/kg and
specific energy of ∼0.5 Wh/kg, while retaining about 80% of
its electroactivity over 10 000 cycles. In addition, we report
on the use of PBEDOT-iI in type III supercapacitors where operating
voltages as high as 2.5 V were achieved with specific energies of
ca. 15 Wh/kg, albeit with limited stability.
Tailor-made additives, which are molecules that share the same molecular structure as a parent molecule with only slight structural variations, have previously been demonstrated as a useful means to control crystallization dynamics in solution. For example, tailor-made additives can be added to solutions of a crystallizing parent molecule to alter the crystal growth rate, size, and shape. We apply this strategy as a means to predictably control morphology in molecular bulk-heterojunction (BHJ) photovoltaic cells. Through the use of an asymmetric oligomer substituted with a bulky triisobutylsilyl end group, the morphology of BHJ blends can be controlled resulting in a near doubling (from 1.3 to 2.2%) in power conversion efficiency. The use of tailor-made additives provides promising opportunities for controlling crystallization dynamics, and thereby film morphologies, for many organic electronic devices such as photovoltaics and field-effect transistors.
A fractional factorial design of experiments allowed us to optimize the areal capacitance of electropolymerized films over 7 variables using a dramatically reduced set of experiments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.